FDA Approved: METOCLOPRAMIDE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for metoclopramide hydrochloride from Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Diabetic Gastroparesis
• Gastroesophageal Reflux Disease
• Postoperative Nausea and Vomiting

Drugs mentioned

• metoclopramide hydrochloride (Metoclopramide hydrochloride)

Snippet

SUPPL AP for METOCLOPRAMIDE (METOCLOPRAMIDE HYDROCHLORIDE)